<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref024">
 <label>24</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Sheffield</surname>
   <given-names>JS</given-names>
  </name>, 
  <name>
   <surname>Siegel</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Mirochnick</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Heine</surname>
   <given-names>RP</given-names>
  </name>, 
  <name>
   <surname>Nguyen</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Bergman</surname>
   <given-names>KL</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Designing drug trials: considerations for pregnant women</article-title>. 
  <source>Clin Infect Dis</source>. 
  <year>2014</year>;
  <volume>59</volume>
  <issue>Suppl 7</issue>:
  <fpage>S437</fpage>â€“
  <lpage>44</lpage>. 
  <pub-id pub-id-type="doi">10.1093/cid/ciu709</pub-id>
  <?supplied-pmid 25425722?>
  <pub-id pub-id-type="pmid">25425722</pub-id>
 </mixed-citation>
</ref>
